VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Return
12.28%
This Quarter Return
+0.42%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.9B
AUM Growth
+$499M
(+36%)
Cap. Flow
+$501M
Cap. Flow
% of AUM
26.36%
Top 10 Holdings %
Top 10 Hldgs %
45.18%
Holding
85
New
22
Increased
26
Reduced
12
Closed
13
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$127M |
| 2 |
Alcon
ALC
|
+$46.3M |
| 3 |
Revolution Medicines
RVMD
|
+$44.1M |
| 4 |
Amicus Therapeutics
FOLD
|
+$43.7M |
| 5 |
Exact Sciences
EXAS
|
+$37.2M |
Top Sells
| 1 |
Insmed
INSM
|
+$82M |
| 2 |
UroGen Pharma
URGN
|
+$23.8M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
+$18.1M |
| 4 |
Liquidia Corp
LQDA
|
+$18.1M |
| 5 |
Establishment Labs
ESTA
|
+$17.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Galapagos
GLPG
$2.15B
| – | – |
-200,000
| Closed | -$5.02M |
|
77
Immunovant
IMVT
$2.86B
| – | – |
-350,000
| Closed | -$5.98M |
|
|
78
Insmed
INSM
$31.1B
| – | – |
-1,075,000
| Closed | -$82M |
|
|
ITOS
79
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-900,000
| Closed | -$5.37M |
|
80
Kiniksa Pharmaceuticals
KNSA
$2.73B
| – | – |
-169,864
| Closed | -$3.77M |
|
|
81
Liquidia Corp
LQDA
$2.39B
| – | – |
-1,227,403
| Closed | -$18.1M |
|
|
82
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-500,000
| Closed | -$18.1M |
|
83
Sarepta Therapeutics
SRPT
$1.85B
| – | – |
-200,000
| Closed | -$12.8M |
|
|
84
UroGen Pharma
URGN
$957M
| – | – |
-2,152,957
| Closed | -$23.8M |
|
|
VRNA
85
Verona Pharma
VRNA
$9.19B
| – | – |
-267,627
| Closed | -$17M |
|